| # | Drug | Count |
|---|---|---|
| 0 | CEFTRIAXONE | 104 |
| 1 | CEFTRIAXONE SODIUM | 95 |
| 2 | FUROSEMIDE | 27 |
| 3 | PEMBROLIZUMAB | 24 |
| 4 | BISOPROLOL FUMARATE | 21 |
| 5 | METFORMIN | 18 |
| 6 | ASPIRIN | 16 |
| 7 | ASPIRIN 325 MG | 16 |
| 8 | ASPIRIN 81 MG | 16 |
| 9 | ESOMEPRAZOLE MAGNESIUM | 16 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | COFFEA TOSTA, AVENA SATIVA, EQUISETUM HYEMALE, HYPERICUM PERFORMATUM, GINKGO BILOBA, GERMANIUM SESQUIOXIDE, SILICEA | 1 | 0.3333 |
| 1 | CEFTRIAXONE SODIUM | 95 | 0.0024 |
| 2 | FLUTAMIDE | 2 | 0.0020 |
| 3 | BETHANECHOL CHLORIDE | 1 | 0.0018 |
| 4 | CABAZITAXEL | 5 | 0.0014 |
| 5 | DINUTUXIMAB | 1 | 0.0012 |
| 6 | AMIKACIN SULFATE | 2 | 0.0011 |
| 7 | DIFLUPREDNATE OPHTHALMIC | 1 | 0.0011 |
| 8 | MIGLITOL | 1 | 0.0010 |
| 9 | DEGARELIX | 5 | 0.0009 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Glycolipid Disialoganglioside-directed Antibody [EPC] | 1 | 0.0009 |
| 1 | Chemokine Receptor Type 4 Interaction [EPC] | 1 | 0.0007 |
| 2 | Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC] | 1 | 0.0004 |
| 3 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 39 | 0.0004 |
| 4 | Echinocandin Antifungal [EPC] | 3 | 0.0004 |
| 5 | Cytomegalovirus DNA Terminase Complex Inhibitor [EPC] | 1 | 0.0003 |
| 6 | CD19-directed Chimeric Antigen Receptor [EPC] | 3 | 0.0003 |
| 7 | CD33-directed Immunoconjugate [EPC] | 1 | 0.0003 |
| 8 | Androgen Receptor Inhibitor [EPC] | 18 | 0.0002 |
| 9 | Antihypoglycemic Agent [EPC] | 1 | 0.0002 |